These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9317087)

  • 1. Sustained response to interferon in a patient with common variable immunodeficiency and hepatitis C.
    Castro F; Santaella M; Torres EA; Rodriguez-Medina JR; González-Keelan C
    Am J Gastroenterol; 1997 Sep; 92(9):1557-8. PubMed ID: 9317087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parameters predicting response to alpha-interferon treatment in chronic hepatitis C.
    Glück T; Seelig R; Dette S; Bühring HJ; Renz M; Kwon S; Wiedmann KH; Weber P
    Hepatogastroenterology; 1997; 44(14):484-91. PubMed ID: 9164523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unusual course of the hepatitis C virus infection in one patient diagnosed of common variable immunodeficiency.
    Múñoz FJ; de la Calle A; Giménez MJ; González J; Conde J
    Allergol Immunopathol (Madr); 1995; 23(6):263-6. PubMed ID: 8579003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why we should treat chronic viral hepatitis.
    King PD
    Postgrad Med; 1996 Sep; 100(3):68-70, 73; discussion 73, 78. PubMed ID: 8795647
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of hepatitis C].
    Trepo C; Habersetzer F; Bailly F; Berby F; Pichoud C; Berthillon P; Vitvitski L
    Pathol Biol (Paris); 1995 Oct; 43(8):716-24. PubMed ID: 8745594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of chronic hepatitis C with interferon-alpha. Clinical histological and virological implications.
    Olaso V; Córdoba J; Berenguer M; Prieto M; Lainez B; Argüello L; Valverde J; Pascual S; Gobernado M; Berenguer J
    Rev Esp Enferm Dig; 1997 Jul; 89(7):531-50. PubMed ID: 9265839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Exacerbation of an autoimmune thrombocytopenic purpura during treatment with interferon alpha in a woman with chronic viral hepatitis C].
    Bacq Y; Sapey T; Gruel Y; Fimbel B; Degenne D; Barin F; Metman EH
    Gastroenterol Clin Biol; 1996; 20(3):303-6. PubMed ID: 8763070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic viral hepatitis and use of interferon. Whom are we treating?
    Koretz RL
    Postgrad Med; 1996 Sep; 100(3):55-7, 61-2, 68. PubMed ID: 8795646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term interferon alpha maintenance therapy for chronic hepatitis C infection in a patient with common variable immune deficiency.
    Willson RA; Fischer SH; Ochs HD
    J Clin Gastroenterol; 1999 Sep; 29(2):203-6. PubMed ID: 10478889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic response to alpha-interferon in chronic alcoholics with viral hepatitis C].
    Nikitin IG; Kuznetsov SL; Liuliaeva OD; Storozhakov GI; Kisliakov VA; Uskov IuI
    Klin Med (Mosk); 1998; 76(8):33-5. PubMed ID: 9770965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha-Interferon retreatment of patients with chronic hepatitis C.
    Rabinovitz M; Block G; Finkelstein SD
    Am J Gastroenterol; 1996 Aug; 91(8):1523-6. PubMed ID: 8759654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy of hepatitis C: patients with cirrhosis.
    Schalm SW; Fattovich G; Brouwer JT
    Hepatology; 1997 Sep; 26(3 Suppl 1):128S-132S. PubMed ID: 9305677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of sustained efficacy of interferon in patients with chronic hepatitis C.
    Vento S; Concia E; Ferraro T
    N Engl J Med; 1996 May; 334(22):1479-80. PubMed ID: 8618600
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chronic viral hepatitis and interferons: preliminary results in 60 patients with chronic hepatitis C and cellular mechanism of action].
    Brenard R; Horsmans Y; Geubel A
    Acta Gastroenterol Belg; 1994; 57(3-4):230-5. PubMed ID: 7810272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and virological response of chronic hepatitis C after treatment with interferon-alpha for 6 or 12 months: predictors of sustained remission.
    Papatheodoridis GV; Katsoulidou A; Touloumi G; Delladetsima JK; Hatzakis A; Tassopoulos NC
    Eur J Gastroenterol Hepatol; 1996 May; 8(5):469-75. PubMed ID: 8804876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience.
    Schvarcz R; Ando Y; Sönnerborg A; Weiland O
    J Hepatol; 1995; 23 Suppl 2():17-21. PubMed ID: 8720289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon treatment of porphyria cutanea tarda associated with chronic hepatitis type C.
    Okano J; Horie Y; Kawasaki H; Kondo M
    Hepatogastroenterology; 1997; 44(14):525-8. PubMed ID: 9164531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Predictive value of a rapid negativity of serum virus C viremia during treatment with interferon alpha in patients with chronic hepatitis C].
    Moulin V; Harzic M; Doll J; Dubeaux B; Ghnassia JC; Andrieu J
    Pathol Biol (Paris); 1996 May; 44(5):468-72. PubMed ID: 8758497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.
    Weiland O; Chen M; Lindh G; Mattsson L; Schvarcz R; Sönnerborg A; Wahl M; Wejstål R; Widell A; Norkrans G
    Scand J Infect Dis; 1995; 27(5):319-24. PubMed ID: 8588128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MALT non-Hodgkin's lymphoma associated with hepatitis C virus infection treated by interferon alpha.
    Bauduer F
    Am J Hematol; 1996 Nov; 53(3):209. PubMed ID: 8895702
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.